Pleiotropy complicates a trade-off between phage resistance and antibiotic resistance
- PMID: 32424102
- PMCID: PMC7260982
- DOI: 10.1073/pnas.1919888117
Pleiotropy complicates a trade-off between phage resistance and antibiotic resistance
Abstract
Bacteria frequently encounter selection by both antibiotics and lytic bacteriophages. However, the evolutionary interactions between antibiotics and phages remain unclear, in particular, whether and when phages can drive evolutionary trade-offs with antibiotic resistance. Here, we describe Escherichia coli phage U136B, showing it relies on two host factors involved in different antibiotic resistance mechanisms: 1) the efflux pump protein TolC and 2) the structural barrier molecule lipopolysaccharide (LPS). Since TolC and LPS contribute to antibiotic resistance, phage U136B should select for their loss or modification, thereby driving a trade-off between phage resistance and either of the antibiotic resistance mechanisms. To test this hypothesis, we used fluctuation experiments and experimental evolution to obtain phage-resistant mutants. Using these mutants, we compared the accessibility of specific mutations (revealed in the fluctuation experiments) to their actual success during ecological competition and coevolution (revealed in the evolution experiments). Both tolC and LPS-related mutants arise readily during fluctuation assays, with tolC mutations becoming more common during the evolution experiments. In support of the trade-off hypothesis, phage resistance via tolC mutations occurs with a corresponding reduction in antibiotic resistance in many cases. However, contrary to the hypothesis, some phage resistance mutations pleiotropically confer increased antibiotic resistance. We discuss the molecular mechanisms underlying this surprising pleiotropic result, consideration for applied phage biology, and the importance of ecology in evolution of phage resistance. We envision that phages may be useful for the reversal of antibiotic resistance, but such applications will need to account for unexpected pleiotropy and evolutionary context.
Keywords: Escherichia coli; bacteriophage; efflux pump; trade-off; virus.
Copyright © 2020 the Author(s). Published by PNAS.
Conflict of interest statement
Competing interest statement: P.E.T. discloses a financial interest in Felix Biotechnology Inc., a company that seeks to commercially develop phages for use as therapeutics, with certain rights to license any patents resulting from this work. A.R.B., B.K.C., and P.E.T. disclose a provisional patent application involving phage therapy.
Figures




References
-
- US Department of Health and Human Services , Antibiotic Resistant Threats in the United States (Centers for Disease Control and Prevention, Atlanta, GA, 2013).
-
- Burmeister A., Abedon S., Turner P., “Bacteriophage ecology” in Encyclopedia of Microbiology, Schmidt T., Ed. (Elsevier, Oxford, UK, 2019), pp. 434–440.
-
- Brockhurst M. A., Koskella B., Experimental coevolution of species interactions. Trends Ecol. Evol. 28, 367–375 (2013). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials